MS patients treated with anti-CD20 therapies ocrelizumab and rituximab have an increased risk of severe COVID-19 infection, whereas treatment with interferon or teriflunomide could reduce that risk. These were the preliminary...
Read More
An Ohio nephrologist was arrested on a misdemeanor assault charge. He had pushed a cardiologist...
Read MoreHow did you do? 1) A post-hoc analysis of AIMS data from a long-term valbenazine study, KINECT 4 to assess the patterns of improvement of patients with TD found that what percentage of patients receiving valbenazine met...
Read More
“I don’t know what these dots are…but ya mind if I connect ‘em?”...
Read More
Are you caught up on breaking trial results released at ASCO GU? Test your knowledge on our Renal...
Read More
“I hope he wasn’t one of your patients…”
Read More
“We’re having a big meeting today to kick off our Employee Wellness Campaign. Did...
Read More
“No, I don’t need a second opinion from your smartphone.”
Read More
MARCH 24, 2021 SEASON: 1 EPISODE: 9
Read MoreWhich of the following is a preliminary outcome of the retrospective, multi-center observational study in a cohort of Italian MS patients investigating the impact of disease-modifying treatments on COVID-19 course of disease?a)...
Read More
In this study on patients with chronic idiopathic urticaria (CIU), 1 month of bloodletting therapy...
Read MoreASCO Genitourinary Cancer Renalv2.indd
Read More
By Physician’s Weekly Blogger, Skeptical Scalpel In the summer of 2018, Bradley Ginn Sr. died in...
Read More
“Impressive. You have the imagined symptoms of a man twice your age.” ...
Read MoreAAO Macular Degeneration Conference Report.indd Featuring Brolucizumab forWet AMD: Assessing Profiles & Early Outcomes Cataract Surgery inWet AMD: Assessing Outcomes & Complications Assessing a Novel Contrast Sensitivity...
Read More[flippingbook width=”100%” height=”auto” ratio=”3:2″ title=”Verzenio – MonarchE”]https://online.flippingbook.com/view/449874131/[/flippingbook] In an extended analysis of the...
Read MoreCertain patients with luminal early breast cancer and up to 3 involved lymph nodes can be treated with adjuvant endocrine therapy alone, according to the primary outcome analysis of the ADAPT HR+/HER2- trial (NCT01779206),...
Read More
1. Join our #PWChat on Twitter, January 21 at 6:30pm EST to learn more! 2. Sign up to be added to...
Read More1) Results released from the Phase 3 CLEAR Trial found that lenvatinib combined with EITHER of these two drugs demonstrated significant benefits over sunitinib in patients with advanced RCC: a) pembrolizumab or...
Read More
